Anthony S. Fauci, MD, director of NIAID, and Tara A. Schwetz, PhD, chief of NIAID Strategic Planning & Evaluation Branch, recently published an article in The Journal of Infectious Diseases discussing the impact advancements in HIV research have had on the broader landscape of infectious diseases research. The article states that scientists have gleaned critical insights into structural biology, immune-mediated diseases, and delivery of clinical and public health interventions.
Dr. Fauci oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis and malaria as well as emerging diseases such as Ebola and Zika. Dr. Fauci has advised five Presidents on HIV/AIDS and many other domestic and global health issues. He was one of the principal architects of the President’s Emergency Plan for AIDS Relief (PEPFAR), a program that has saved millions of lives throughout the developing world.
Dr. Tara Schwetz is the chief of the Strategic Planning and Evaluation Branch at NIAID. Her team provides the Office of the Director scientific analysis of NIAID’s progress toward the institute’s strategic goals, including NIAID’s large portfolio of HIV/AIDS research and training grants. After completing her postdoctoral fellowship at Vanderbilt University Medical Center, she joined the National Institutes of Health in 2014.
You can read the article here.